2007-February Archives by Thread

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...

Starting: Thu Feb 1 03:40:03 2007
Ending: Wed Feb 28 17:47:21 2007
Messages: 194

• [Ip-health] CL situation in Thailand   tui
• [Ip-health] PhRMA's Seven Deadly Lies about Thai Compulsory Licenses   B.Baker@neu.edu
• [Ip-health] US-India IP MOU text   Benjamin Krohmal
• [Ip-health] Email alert: February issue of the WHO Bulletin   bulletin
• [Ip-health] Compulsory licensing of patents, outside of the Thai case   James Packard Love
• [Ip-health] Compulsory licensing of patents, outside of the Thai case   Prof. Michael H. Davis
• [Ip-health] The FT's on the "consensus" that compulsory licenses should not be used for heart disease   James Packard Love
• [Ip-health] WHO raps compulsory licensing plan. Govt urged to seek talks with drug firms   Alexandra HEUMBER
• [Ip-health] ICTSD publication: Guidelines for the examination of pharmaceutical patents   Judit Rius Sanjuan
• [Ip-health] Public Access to Research Letter -deadline extended   Benjamin Krohmal
• [Ip-health] WHO raps compulsory licensing plan Govt urged to seek talks with drug firms   Kannikar KIJTIWATCHAKUL
• [Ip-health] RE: Ip-health digest, Vol 1 #2251 - 1 msg   Seumas Miller
• [Ip-health] Pascal Lamy on earlier efforts to limit the scope of diseases for compulsory licenses   James Packard Love
  • [Ip-health] RE: Pascal Lamy on earlier efforts to limit the scope of diseases for compulsory licenses   Jean-Charles.Van-Eeckhaute@ec.europa.eu
    • [Ip-health] RE: Pascal Lamy on earlier efforts to limit the scope of diseases for compulsory licenses   James Packard Love
• [Ip-health] Le Monde diplomatique article on 2002/2003 CL/scope of disease debate   James Packard Love
• [Ip-health] TODAY: James Love presents at NYC School of Law   Malini Aisola
• [Ip-health] Request for Information/help   Emmanuel Alphonce
• [Ip-health] =?iso-8859-1?Q?Malaysia_-_Attorney-General_Defends_Generic_Medicines_Befo?= =?iso-8859-1?Q?re_UN_Rights_Body_?=   3D -> Trade - Human Rights - Equitable Economy
• [Ip-health] KEI Brownbag re WIPO Development Agenda February 9, 2007   Thiru Balasubramaniam
• [Ip-health] Generic companies sue Wyeth for antibiotic Zosyn patent evergreening   Judit Rius Sanjuan
• [Ip-health] IPS: WHO chief's stand on generic drugs slammed   Thiru Balasubramaniam
• [Ip-health] =?iso-8859-1?Q?FW:_Malaysia_-_Attorney-General_Defends_Generic_Medicines_?= =?iso-8859-1?Q?Before_UN_Rights_Body_?=   3D -> Trade - Human Rights - Equitable Economy
• [Ip-health] 2 articles on big pharma & innovation   Benjamin Krohmal
• [Ip-health] FTAs, The Challenge of Implementation   Dalindyebo Bafana Shabalala
• [Ip-health] Questions over future of Big Pharma   Michelle Childs
• [Ip-health] Government of India press announcement: INDIA HOSTS FIRST EVER INTERNATIONAL MEET ON IPR   Thiru Balasubramaniam
• [Ip-health] editorial: Thai CLs, Novartis case, and the IGWG   Benjamin Krohmal
• [Ip-health] Financial Times on Thai Compulsory Licenses - let them die so Pharma can sell to the middle class   B.Baker@neu.edu
• [Ip-health] Novartis open letter defending it's Glivec legal challenge in India   James Packard Love
• [Ip-health] Deconstruction of Novartis's defense of its challenge to the India patent regime   B.Baker@neu.edu
• [Ip-health] NYT: Indonesia may sell but not give bird flu virus to scientists   Suerie Moon
• [Ip-health] Novartis Open Letter regarding the Glivec legal challenge in India   julie.patel@keionline.org
• [Ip-health] British scientists find patent loophole   Tim Hubbard
• [Ip-health] Profiting from Avian Flu - Tamiflu boosts drug firm's profit   Riaz K Tayob
• [Ip-health] Novartis appoints Stephanie Moss to produce inspired incentive trip   Joana Ramos
• [Ip-health] Lyme disease guidelines may violate antitrust laws   James Love
• [Ip-health] REMINDER: tomorrow brown bag re WIPO Development agenda 12:30   Manon Ress
• [Ip-health] Stephen Lewis calls on DG Chan to reverse position on Thai CL   Thiru Balasubramaniam
• [Ip-health] 1.5 billion AMC launched, no US support   Benjamin Krohmal
• [Ip-health] IP-Watch: Debate On Malaria And Trade Flexibilities At WHO   Thiru Balasubramaniam
• [Ip-health] (no subject)   Daumerie, Denis Paul Jacques
• [Ip-health] Open Letter to WHO/UNAIDS India re Margaret Chan's Comments on Thai CL   chan park
• [Ip-health] Roger Bate in the Wall Street Journal: Thai-ing Pharma Down   Thiru Balasubramaniam
• [Ip-health] The Hindu on Plagiarism in the Mashelkar Committee Report   chan park
• [Ip-health] Flaws, plagiarism in Mashelkar Report   chan park
  • [Ip-health] Re: [Commons-Law] Flaws, plagiarism in Mashelkar Report   chan park
• [Ip-health] Cancer Patients Aid Association Responds to Max Foundation   chan park
• [Ip-health] WHO letter to Thai government concerning CL   tui
• [Ip-health] SciDev.Net: Thailand backs off threat to break drug patents   Johanna von Braun
• [Ip-health] Ambassador Susan Schwab, USTR response to James Love of KEI's letter in regards to Thailand's legal issuance of a compulsory license on a patented medicine.   julie.patel@keionline.org
• [Ip-health] KEI Submission: Special 301 Review   Judit Rius Sanjuan
• [Ip-health] Dr. Margaret Chan letter to Thai MOH regarding Thai CL   James Love
• [Ip-health] WHO expertise on IP issues   James Packard Love
• =?windows-874?Q?Re: [Ip-health] Dr. Margaret Chan letter to Thai MOH regarding Thai CL?=   =?windows-874?Q?sangsiri teemanka?=
• [Ip-health] Open letter to Novartis' CEO from Members of the European Parliament   Alexandra HEUMBER
• [Ip-health] URL fixed for Chan letter   James Packard Love
• [Ip-health] European Parliament's Press conference tomorrow 14th on the Novartis case against India   Alexandra HEUMBER
• [Ip-health] public health sign-on for 2/14 Ways & Means trade hearing   Ellen Shaffer
• [Ip-health] HEALTH-INDIA: Campaign to Stop Monopoly of Clinical Trial Data   Joana Ramos
• [Ip-health] KEI and CPTech   James Packard Love
• [Ip-health] Church leaders call on Novartis to drop legal case in India   Jean Blaylock
• [Ip-health] NYT-Op-Ed "Patenting Life" by Michael Crichton   Suerie Moon
• [Ip-health] Thailand to issue CLs on 14 drugs?   Benjamin Krohmal
• [Ip-health] SUNS: Flurry of activity before next week's Development meeting   Sangeeta
• [Ip-health] Letter from Rep. Henry Waxman to Novartis (Rohit Malpani)   Rohit Malpani
• [Ip-health] FTC ASKED TO INVESTIGATE GILEAD EFFORT TO CONTROL MARKET FOR AIDS DRUGS INGREDIENTS   James Packard Love
• [Ip-health] US-Panama TPA: draft text public   GRAIN LB
• [Ip-health] Novartis Hearing update, 15.02.07   chan park
• [Ip-health] WHO DG regrets her C-License statement   martin khor
• [Ip-health] CPAA responds to Novartis' Open Letter   chan park
  • [Ip-health] Anti-Novartis protest during Boston blizzard yesterday-link to video   Katharine Krauss
• [Ip-health] FTC compels Compulsory License in Rambus antitrust case   Judit Rius Sanjuan
• [Ip-health] Pharmalot on KEI FTC-Gilead complaint   Judit Rius Sanjuan
• [Ip-health] Max Foundation says other advocates misguided on Novartis   Benjamin Krohmal
• [Ip-health] MSF, Oxfam: Former Swiss President joins Call for Novartis to Drop its Case in India   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] FTC on Patent Reform   James Love
• [Ip-health] EU , US oppose Novartis Glivec Move   Gopa Kumar
• [Ip-health] SUNS: TRIPS/CBD, ENFORCEMENT DOMINATE TALKS AT TRIPS COUNCIL   Sangeeta
• [Ip-health] Opposition Gains Support Against Novartis Patent Lawsuit In India   Alexandra HEUMBER
• [Ip-health] Senate Passes Reverse Payment Bill   James Love
• [Ip-health] Letter to Indian Government - Brazilian NGOs   Gabriela Chaves
• [Ip-health] Novartis Update, 16.02.07   chan park
• [Ip-health] NYTimes: WHO should encourage vaccine production transfer   Peter Maybarduk
• [Ip-health] Stiglitz critic with Colombian/US FTA & defends public ownership   Judit Rius Sanjuan
• [Ip-health] New blog post: Debate on the WIPO Development Agenda   Malini Aisola
• [Ip-health] Merck/Gilead's roll out of Atripla in developing countries   James Packard Love
• [Ip-health] Novartis story in Frontline Magazine   chan park
• [Ip-health] Action Alert, Novartis Case   Gopa Kumar
  • [Ip-health] Novartis, Article 27 of TRIPS and Mashelkar Report   dshanker@deakin.edu.au
• [Ip-health] More from Frontline   chan park
• [Ip-health] Re: Ip-health digest, Vol 1 #2262 - 14 msgs   Gopa Kumar
• [Ip-health] US Congressional debate: Patent Reform is in the Air   James Love
• [Ip-health] Debate on WIPO Development Agenda   James Packard Love
• [Ip-health] TRIPS,Indian Constitution and Novartis Case   ravi srinivas
• [Ip-health] FromGeneva: New Chair of WIPO Committee dealing with Development Agenda   Thiru Balasubramaniam
• [Ip-health] Economic Times: Mashelkar Prescription May Get Second Opinion   chan park
• [Ip-health] Lopinavir Crystalline - EP1268442 (WO 00174787)- Rejected by EPO   Judit Rius Sanjuan
• [Ip-health] GSK, WHO, a patient group and USD 10,000   Judit Rius Sanjuan
• [Ip-health] Press Release: Generic Biotech Medicines Could Save Plan Sponsors and Patients $71 Billion   James Packard Love
• [Ip-health] Novartis Pay Chief Upcoming Re-election to Be Opposed by Ethos   Joana Ramos
• [Ip-health] Gilead's Gold Mine   James Packard Love
• [Ip-health] OFT report recommends reform to UK drug pricing scheme   Michelle Childs
• [Ip-health] KEI general statement @ 3rd Session of WIPO PCDA   Thiru Balasubramaniam
• [Ip-health] American Antitrust Institute Amicus brief in Tamoxifen   James Packard Love
• [Ip-health] Will the real Novartis stand up...   Ellen T HOEN
• [Ip-health] Pharma industry's allegations baseless, no question of siding with MNCs: Dr Mashelkar   Gopa Kumar
• [Ip-health] General Statement by Pakistan at 3rd WIPO PCDA   Thiru Balasubramaniam
• [Ip-health] Interview with Thai Health Minister on CLs   Benjamin Krohmal
• [Ip-health] Day 1 of WIPO PCDA 3, talking to the India Delegation   Malini Aisola
• [Ip-health] WSJ editorial: "Theft in Thailand"   Benjamin Krohmal
• [Ip-health] Philippines House of Representatives enacts amendments to Intellectual Property Law   Rohit Malpani
  • [Ip-health] Philippines House of Representatives enacts amendments to Intellectual Property Law   Jeff Williams
  • [Ip-health] Philippines House of Representatives enacts amendments to Intellectual Property Law   Intal - Wim De Ceukelaire
• [Ip-health] IP-Watch: Investigation Finds WIPO Head Repeatedly Misreported His Age   Thiru Balasubramaniam
• [Ip-health] Consumers International General Statement to 3rd Session of the WIPO PCDA   Thiru Balasubramaniam
• [Ip-health] No Conflict of Creeds: WIPO Delegates discuss the public domain   Thiru Balasubramaniam
  • [Ip-health] RE: [A2k] Library Copyright Alliance Statement to WIPO on Public Domain   Miriam M. Nisbet
• [Ip-health] Tripartite alliance against the public domain: Colombia, El Salvador and Italy   Thiru Balasubramaniam
• [Ip-health] WHO IGWG: Fast track accreditation for NGOs   spring.gombe@cptech.org
• [Ip-health] another op-ed smears Thai CLs   Benjamin Krohmal
• [Ip-health] France blocks generic biologics   Benjamin Krohmal
• [Ip-health] Consumers International statement to WIPO PCDA (competition policy and the public domain)   Thiru Balasubramaniam
• [Ip-health] health groups support on-line access to medical research   Benjamin Krohmal
• [Ip-health] WHO Director-General Margaret Chan reshuffles management team of WHO   Thiru Balasubramaniam
• [Ip-health] Thailand Publishes White Papers on Issuance of Compulsory Licenses   Mike Palmedo
• [Ip-health] Latest draft for Cluster B   Malini Aisola
• [Ip-health] The Hindu: Mashelkar Committee Withdraws Report   chan park
• [Ip-health] Indian Express: ‘Plagiarism’ in his panel’s report, Mashelkar tells Govt to withdraw it   chan park
  • [Ip-health] Indian Express: Plagiarism in his panels report, Mashelkar tells Govt to withdraw it   dshanker@deakin.edu.au
• [Ip-health] Novartis Hearing update, 22.02.07   chan park
• [Ip-health] March 20, 2007: EC Competition Policy on Patent Pools hosted in Brussels.   James Love
• [Ip-health] Times of India, The Hindu: Mashelkar takes back report after plagiarism row   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] WHO IGWG: Fast track accreditation for NGOs - clarification message from WHO   Daumerie, Denis Paul Jacques
• [Ip-health] Patent law report withdrawn : Committee chief Mashelkar cites plagiarism as the reason.   Joana Ramos
• [Ip-health] Text of Mashelkar Letter to Ministry of Commmerce   chan park
• [Ip-health] FromGeneva: Colombia, the Public Domain and the Development Agenda   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Text-Based Negotiations On A WIPO Development Agenda Pick Up Pace   Thiru Balasubramaniam
• [Ip-health] Indonesia's action on bird-flu virus sample   martin khor
• [Ip-health] Indonesia wants new vaccine sharing system   martin khor
• [Ip-health] [Indian Express] Pharmacy or Lab?   Achal Prabhala
• [Ip-health] [Business Standard] Scrap panel on patents: CPM to govt   Achal Prabhala
• [Ip-health] [ManagingIP] Mashelkar withdraws Indian patent report   Achal Prabhala
• [Ip-health] [DNA India] Experts, Left trash report by Mashelkar   Achal Prabhala
• [Ip-health] [Economic Times] Allow incremental patents   Achal Prabhala
• [Ip-health] Colombia against public domain   James Packard Love
  • [Ip-health] Re: [A2k] Colombia against public domain   Robin Gross
• [Ip-health] Pakistan's Perspectives on Proposals at the PCDA   Malini Aisola
• [Ip-health] (Final Draft) Cluster B: Norm-Setting, Flexibilities, Public Policy and Public Domain   Thiru Balasubramaniam
• [Ip-health] Drug firms defend advocacy   Intal - Wim De Ceukelaire
• [Ip-health] Econ Times: Copycat drug cos convert, back MNCs on patents   Mike Palmedo
  • [Ip-health] Econ Times: Copycat drug cos convert, back MNCs on patents   Mira Shiva
• [Ip-health] PCDA 3 -- Its a done deal, and it's a good deal   James Love
• [Ip-health] Bravi   Philippe AIGRAIN
• [Ip-health] Delegate and NGO quotes on WIPO Development Agenda outcome for PCDA 3   Thiru Balasubramaniam
• [Ip-health] WIPO embraces reform on intellectual property mission   James Packard Love
• [Ip-health] (no subject)   chan park
  • [Ip-health] (no subject)   James Packard Love
• [Ip-health] [Times of India] Mashelkar draws health activists' ire   Achal Prabhala
• [Ip-health] BusinessWorld: Mashelkar retreats   chan park
• [Ip-health] Novartis Hearing update, 23.02.07   chan park
• [Ip-health] Indian Express: Plagiarised report figures in Novartis hearing   Achal Prabhala
• [Ip-health] Outlook: "Certain Inaccuracies Have Crept In" ++ Why was the report withdrawn?   Achal Prabhala
• [Ip-health] Indian Express - Mashelkar replies: I stand by the patent report, 100 per cent   Achal Prabhala
• [Ip-health] Bailey's scientific perspective benefits Novartis-- abt. Anne Bailey, head of corporate communications for Novartis AG   Joana Ramos
• [Ip-health] Re: [Commons-Law] DNA: Empty Allegations   Sunil Abraham
  • [Ip-health] Re: [Commons-Law] DNA: Empty Allegations   chan park
    • [Ip-health] Re: [Commons-Law] DNA: Empty Allegations   Mira Shiva
  • [Ip-health] Re: [Commons-Law] DNA: Empty Allegations   atulkaushik@nic.in
• [Ip-health] DNA: Empty Allegations   Achal Prabhala
• [Ip-health] DNA: Empty Allegations   Achal Prabhala
• [Ip-health] Novartis' Vasella to face shareholders' wrath at upcoming AGM - report   Joana Ramos
• [Ip-health] NY Times editorial: "A necessary vaccine"   Peter Maybarduk
• [Ip-health] IP-Watch: Informative Debate On IP And Drug Price Model, Flexibilities   Thiru Balasubramaniam
  • [Ip-health] IP-Watch: Informative Debate On IP And Drug Price Model, Flexibilities   James Packard Love
    • [Ip-health] IP-Watch: Informative Debate On IP And Drug Price Model, Flexibilities   James Packard Love
• [Ip-health] SUNS: Development meeting discusses norm setting, technical assistance   Sangeeta
• [Ip-health] SUNS: Intensive consultations to narrow divisions on "Development Agenda"   Sangeeta
• [Ip-health] Fedefarma asks USTR to put Guatemala on 301 list   Mike Palmedo
• [Ip-health] WIPO PCDA (Third Session): Summary by Chair and Recommendations   Thiru Balasubramaniam
• [Ip-health] Stiglitz on Trips and Prize funds   Michelle Childs
• [Ip-health] DNA: Empty Allegations   James Packard Love
• [Ip-health] China New Rules For Drug Pricing   Judit Rius Sanjuan
• [Ip-health] Times of India: Mashelkar is not new to plagiarism   Sunil a
• [Ip-health] (Fox News) One for the Ages: U.N. Official Uses Two Birthdates   Thiru Balasubramaniam
• [Ip-health] (AP) Audit: U.N. Unit Boss Used 2 Birth Dates   Thiru Balasubramaniam
• [Ip-health] UK OFT REPORT ON PHARMACEUTICAL PRICING   charlesclift@tiscali.co.uk
• [Ip-health] Central American exports to US not increasing with CAFTA (Bloomberg)   Mike Palmedo
• [Ip-health] Economic Times: IPI comes clean on Mashelkar report   chan park
• [Ip-health] Foreign pharmaceutical companies form association in Serbia   Joana Ramos
• [Ip-health] Putin says foreign drugmakers earn too much on Russian program   Joana Ramos
• [Ip-health] Mashelkar - Times of India article   g.m.dutfield@qmul.ac.uk
• [Ip-health] SUNS: WIPO Committee Agrees to 24 Development Agenda proposals   Sangeeta
• [Ip-health] Major Pharmaceutical Brands Vie For Top Honors at DTC National Advertising Awards   Joana Ramos

Last message date: Wed Feb 28 17:47:21 2007
Archived on: Wed Feb 28 17:47:22 2007

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...